These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25426682)

  • 1. Minoxidil topical solution: an unsafe product for children.
    Claudet I; Cortey C; Honorat R; Franchitto N
    Pediatr Emerg Care; 2015 Jan; 31(1):44-6. PubMed ID: 25426682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minoxidil intoxication, the pharmacological agent of a hair lotion].
    Aprahamian A; Escoda S; Patteau G; Merckx A; Chéron G
    Arch Pediatr; 2011 Dec; 18(12):1302-4. PubMed ID: 22001642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory hypotension due to Rogaine® (minoxidil) ingestion managed with midodrine.
    Garrard A; Wood A; Sollee D; Aaronson P
    Clin Toxicol (Phila); 2011 Dec; 49(10):907-9. PubMed ID: 22077158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of minoxidil toxicosis in a dog.
    Jordan TJM; Yaxley PE; Culler CA; Balakrishnan A
    J Am Vet Med Assoc; 2018 Jan; 252(2):222-226. PubMed ID: 29319439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia.
    Maqoud F; Zizzo N; Mele A; Denora N; Passantino G; Scala R; Cutrignelli A; Tinelli A; Laquintana V; la Forgia F; Fontana S; Franco M; Lopedota AA; Tricarico D
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00585. PubMed ID: 32378360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical minoxidil: accidental poisoning in children.
    Prescrire Int; 2015 Apr; 24(159):97. PubMed ID: 25941701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil: review of efficacy and safety.
    Katz HI
    Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of oral minoxidil in the treatment of alopecia areata.
    Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
    Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minoxidil overdose with ECG changes: case report and review.
    Poff SW; Rose SR
    J Emerg Med; 1992; 10(1):53-7. PubMed ID: 1629592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hairy fall: syncope resulting from topical application of minoxidil.
    Dubrey SW; VanGriethuysen J; Edwards CM
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26347235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of androgenic alopecia with topical minoxidil].
    Brenner S; Tamir A
    Harefuah; 1991 Nov; 121(9):297-302. PubMed ID: 1800277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe toxicity from ingestion of a topical minoxidil preparation.
    McCormick MA; Forman MH; Manoguerra AS
    Am J Emerg Med; 1989 Jul; 7(4):419-21. PubMed ID: 2735992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdose of Rogaine Extra Strength for Men topical minoxidil preparation.
    Farrell SE; Epstein SK
    J Toxicol Clin Toxicol; 1999; 37(6):781-3. PubMed ID: 10584592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minoxidil 5% solution for topical treatment of loose anagen hair syndrome.
    Chandran NS; Oranje AP
    Pediatr Dermatol; 2014; 31(3):389-90. PubMed ID: 24602086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy.
    Benmously Mlika R; Ben Hamida M; Hammami H; Dorbani Ben Thabet I; Rouatbi M; Mokhtar I
    J Cosmet Laser Ther; 2013 Aug; 15(4):217-8. PubMed ID: 23463948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical minoxidil: its use in treatment of male pattern baldness.
    Kulick MI
    Ann Plast Surg; 1988 Sep; 21(3):273-5. PubMed ID: 3066259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.